In the last trading session, 1.79 million Matinas Biopharma Holdings Inc (AMEX:MTNB) shares changed hands as the company’s beta touched 1.70. With the company’s per share price at $0.90 changed hands at $0.2 or 29.37% during last session, the market valuation stood at $5.66M. MTNB’s last price was a discount, traded about -2288.89% off its 52-week high of $21.50. The share price had its 52-week low at $0.50, which suggests the last value was 44.44% up since then. When we look at Matinas Biopharma Holdings Inc’s average trading volume, we note the 10-day average is 0.79 million shares, with the 3-month average coming to 169.17K.
Matinas Biopharma Holdings Inc (AMEX:MTNB) trade information
Instantly MTNB was in green as seen at the end of in last trading. With action 58.62%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -91.67%, with the 5-day performance at 58.62% in the green. However, in the 30-day time frame, Matinas Biopharma Holdings Inc (AMEX:MTNB) is -71.70% down. Looking at the short shares, we see there were 80434.0 shares sold at short interest cover period of 2.24 days.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Matinas Biopharma Holdings Inc (MTNB) estimates and forecasts
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 7.12%. The 2024 estimates are for Matinas Biopharma Holdings Inc earnings to increase by 19.55%.
Matinas Biopharma Holdings Inc (AMEX:MTNB)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 2.53% of Matinas Biopharma Holdings Inc shares while 27.99% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 28.72%. There are 27.99% institutions holding the Matinas Biopharma Holdings Inc stock share, with HIGHBRIDGE CAPITAL MANAGEMENT LLC the top institutional holder. As of 2024-06-30, the company held 4.8971% of the shares, roughly 10.64 million MTNB shares worth $1.68 million.
VANGUARD GROUP INC holds the second largest percentage of outstanding shares, with 4.2869% or 9.32 million shares worth $1.48 million as of 2024-06-30.
